06:48 AM EST, 02/25/2025 (MT Newswires) -- Maravai Lifesciences ( MRVI ) announced Tuesday that it is postponing its Q4 earnings release and conference call from Feb. 25 to March 18.

The company said it will file a late-notification form with the US Securities and Exchange Commission and delay its annual report for the year ending Dec. 31, 2024.

Maravai added that it needs extra time to evaluate a potential non-cash impairment charge on goodwill from its acquisition of Alphazyme.

The company is assessing internal controls to fix a material weakness in its revenue recognition process and reviewing a revenue recognition error that recorded about $3.9 million in the wrong quarter, according to the company.

The error is not expected to influence the company's annual guidance, Maravai Lifesciences ( MRVI ) added.

Shares of the company were down nearly 13% in recent trading.